What the label lists and what reports show
Ammonium lactate side effects
Ammonium lactate's FDA label lists its adverse reactions in its own words. FAERS holds 2,119 reports naming it through July 30, 2026; the reaction reported most often, leaving out the conditions it is used for, product-use terms and outcomes, is fatigue (149 reports).
- Generic listed
Check it at the source: the ammonium lactate FDA label on DailyMed (effective November 30, 2025, Padagis Israel Pharmaceuticals Ltd); the FDA FAERS public dashboard.
What does the label list?
From the label: adverse reactionsIn controlled clinical trials of patients with ichthyosis vulgaris, the most frequent adverse reactions in patients treated with ammonium lactate cream were rash (including erythema and irritation) and burning/stinging. Each was reported in approximately 10-15% of patients. In addition, itching was reported in approximately 5% of patients. In controlled clinical trials of patients with xerosis, the most frequent adverse reactions in patients treated with ammonium lactate cream were transient burning, in about 3% of patients, stinging, dry skin and rash, each reported in approximately 2% of patients.
Source: FDA drug label, Padagis Israel Pharmaceuticals Ltd, effective November 30, 2025 (SPL set 7096d38e-2bd1-4374-9bf6-7fd09ef7509c), via openFDA; the full label on DailyMed
What do FAERS reports show?
2,119 reports list ammonium lactate among the medicines taken, each a report of something that happened, not proof the medicine caused it; 175 are coded as a death and 578 as a hospital stay. Counts follow how widely a medicine is used and watched, and they are not a measure of how risky it is. Of the 21 reactions below, 1 is named by the same term (in US spelling) in the label's adverse reactions, warnings or patient leaflet; a reaction the label does not name may still be there under another word, and a report does not show that the medicine caused it.
Reports received each year
The 25 most reported reactions
Source: FDA Adverse Event Reporting System (FAERS) via openFDA, reports through July 30, 2026; reactions as MedDRA preferred terms
What next?
- Ammonium lactate: the full record
- label, generics, price, shortages, recalls
- Report a side effect to the FDA
- MedWatch
- Side effects hub
- the most reported medicines and reactions